Akira Ishiyama

Professor

University of California, Los Angeles
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (18)

Hypothesis: Calcitonin gene-related peptide (CGRP), a neuropeptide implicated in nociception, localizes to areas of heightened pain sensitivity during cochlear implantation (CI) under local anesthesia with monitored anesthesia care (MAC). Background: Many elderly patients would benefit from CI; however, implantation is often limited by medical comorbidities and risks of general anesthesia including postoperative cognitive decline. CI under local anesthesia with MAC offers a safer alternative; however, optimal analgesia remains unclear due to limited data on pain receptor distribution in the temporal bone. CGRP is a well-established marker in pain signaling pathways. The present study aims to describe its distribution in relation to CI as well as the anesthetic technique utilized at the University of California, Los Angeles (UCLA) in the very elderly. Methods: Archival human temporal bones (HTB) acquired from healthy donors were stained for CGRP and neurofilament (NF). Findings were used to inform analgesic techniques in 17 very elderly patients (age >80 y) undergoing CI under local anesthesia with MAC. Results: CGRP immunoreactivity (IR) was observed in the facial nerve, tympanic membrane, and epithelium of the external auditory canal—regions corresponding to areas of reported intraoperative discomfort. Modifying the analgesic approach with a targeted bony-cartilaginous injection improved patient tolerance. No major complications occurred, and all procedures were completed without conversion to general anesthesia. Conclusion: CGRP is a valuable marker for identifying pain-sensitive regions in the temporal bone relevant to CI. Histopathology-guided refinements in local anesthesia enhance intraoperative comfort and feasibility of CI under MAC in the very elderly with the potential to improve postoperative outcomes and broaden candidacy for this population.

Year:

2026

Hypothesis: Endolymph volumes within the cochlea and vestibule differ between Meniere's disease (MD) and similar-age controls. Background: Magnetic resonance imaging (MRI) has potential to diagnose endolymphatic hydrops (EH). In this study, we utilize archival human temporal bones (HTB) to establish objective reference values for endolymph volumes within the cochlea and vestibule in patients with MD and in age-similar controls, for correlation with future MRI studies. Methods: Nineteen HTBs were selected for 3-dimensional reconstruction and volume analysis, including 12 HTBs with MD and 7 age-similar control HTBs. HTBs were segmented and volumes of interest were measured allowing for calculation of the vestibular and cochlear endolymphatic ratios (vELR and cELR), representative of the degree of EH within the vestibule and cochlea. Results: Endolymph volumes within the vestibule and cochlea were significantly higher in MD HTBs. There was no difference in volumes of the bony vestibule and cochlea. The vELR and cELR were significantly larger in MD. Control HTB measurements were utilized to establish the upper bound of normal for the vELR and cELR, which were determined to be 33.2% and 8.84%, respectively. Conclusions: Endolymph volumes and the corresponding vELR and cELR values were significantly higher in MD, indicative of EH. Through the ELR, this study provides objective anatomic reference values directly comparable to MRI studies of EH. A threshold for the vELR and cELR is proposed, above which a diagnosis of EH may be warranted.

Year:

2026

Hypothesis: Degenerative changes in the neurovascular unit (NVU) in the human spiral ganglia (SG) in patients with Meniere's disease (MD) compared with normal patients underlie the clinical manifestations of MD. Background: Endolymphatic hydrops (EH) is the pathologic correlate of MD, yet the etiology of MD is poorly understood. EH alone does not adequately explain the changes in permeability of the cochlear blood-labyrinthine barrier seen with delayed contrast MRI or fluctuations in symptoms. Methods: Hematoxylin and eosin sections of the cochlea were obtained from temporal bones of normal patients (n=5, age: 47 to 63 y, 1 male/4 female) and patients diagnosed with MD (n=8, age 51 to 88, 4 male/4 female). The number of spiral ganglia neurons (SGNs) in each cochlea was estimated. SGNs and blood vessels in the cochlea from normal and MD patients (archival celloidin sections from the same patients) were reliably identified with antibodies against acetylated-3-tubulin and glucose transporter-1, respectively, and visualized by immunofluorescence and laser confocal microscopy. Results: There was a significant decrease (50% loss) of SGNs among patients diagnosed with MD compared with age-matched controls ( P <0.05) and contralateral unaffected cochlea (35% decrease). Immunofluorescence-stained sections showed a marked decrease of blood vessels and a corresponding loss of SGNs in MD cochlea compared with controls. Conclusions: The decrease of spiral ganglia neurons and associated blood vessels showed regional damage of the cochlea. These results suggest that the NVU interaction may be critical to preserve the SGNs in MD and establish a framework for understanding the etiology and treatment of MD beyond EH. Level of Evidence: Not applicable.

Year:

2025

Year:

2025

Year:

2025

Hypothesis The objective of this study is to obtain comprehensive morphometric measurements of the incomplete partition type II (IP-II) cochlea to provide a better understanding of intracochlear anatomy and important considerations for electrode selection and insertion. Background IP-II is the most common bony inner ear malformation that often requires cochlear implantation. Currently, there is significant controversy on electrode selection due to a lack of research that can provide reliable, high-resolution measurements. Methods Three-dimensional reconstructions of the cochlea were made from hematoxylin and eosin–stained slides from 11 archival human temporal bones from 8 adult IP-II patients (one paired) and 2 fetuses. Detailed measurements of the angular and linear length of the spiral ganglion neurons and cochlear duct at the modiolar and lateral wall of the scala tympani as well as cross-sectional areas and vertical height measurements of the scala tympani at 90-degree intervals were measured. Results The spiral ganglia neurons terminated at 540.5 ± 45.4 degrees, which corresponded to the beginning of the interscalar septal defect. The corresponding Rosenthal's canal length was 12.75 ± 0.82 mm, and the lateral wall length was 23.95 ± 1.04. The average cochlear duct length was 32.44 mm ± 1.58 mm, corresponding to an average angular distance of 951.6 ± 80 degrees. The modiolar height demonstrated less variation within the scala tympani but was significantly smaller at 0 and 90 degrees compared with the normal cochlea. The lateral wall height was also significantly smaller at 0, 180, and 540 degrees. There was a drastic decrease in lateral wall height at 540 degrees to 0.4 mm, which is smaller than the apical dimension of many electrodes. Conclusion This is the first study to provide detailed morphometric measurements of the IP-II cochlea including spiral ganglion neuron length and scala tympani height. These measurements directly relate to electrode selection for cochlear implantation.

Year:

2025

Objective: Nontuberculosis mycobacteria (NTM) infection of cochlear implants are exceedingly rare. Here, we report one such case and review the literature surrounding previous reports. Methods: Case report. Case Report: A 76‐year‐old female underwent right cochlear implantation. Her course was complicated by wound dehiscence, three surgical debridements, and ultimately explantation. Cultures ultimately grew Mycobacterium abscessus , which was effectively treated with Azithromycin, Omadacycline, and 3 months of injectable Cefoxitin. At the latest follow‐up, the patient is without evidence of further infection and pending reimplantation. Conclusion: NTM is a rare cause of postsurgical infections following cochlear implantation. It is especially important to consider this in cases of indolent, antibiotic‐resistant infections to optimize patient treatment.

Year:

2025

Objective: To investigate the role and distribution of various molecular markers using immunohistochemistry and immunofluorescence to further elucidate and understand the pathogenesis of otosclerosis. Methods: Archival celloidin formalin-fixed 20-micron thick histologic sections from 7 patients diagnosed with otosclerosis were studied and compared to controls. Sections in the mid-modiolar region were immunoreacted with rabbit polyclonal antibodies against nidogen-1, β2-laminin, collagen-IX, BSP, and monoclonal antibodies against TGF β-1 and ubiquitin. Digital images were acquired using a high-resolution light and laser confocal microscope. Results: Nidogen-1, BSP, and collagen-IX were expressed in the otospongiotic regions, and to lesser extent, in the otosclerotic regions, the latter previously believed to be inactive. β2-laminin and ubiquitin were uniformly expressed in both otospongiotic and otosclerotic regions. There was a basal level of expression of all of these markers in the normal hearing and sensorineural hearing loss specimens utilized as control. TGF β -1, however, though present in the otosclerosis bones, was absent in the normal hearing and sensorineural hearing loss controls. Conclusions: Our results propose that the activity and function of TGF-1 may play a key role in the development and pathogenesis of otosclerosis. Further studies utilizing a higher number of temporal bone specimens will be helpful for future analysis and to help decipher its role as a potential target in therapeutic interventions.

Year:

2024

Purpose NF2 -related schwannomatosis (NF2) is characterized by bilateral vestibular schwannomas (VS) often causing hearing and neurologic deficits, with currently no FDA-approved drug treatment. Pre-clinical studies highlighted the potential of mTORC1 inhibition in delaying schwannoma progression. We conducted a prospective open-label, phase II study of everolimus for progressive VS in NF2 patients and investigated imaging as a potential biomarker predicting effects on growth trajectory. Methods The trial enrolled 12 NF2 patients with progressive VS. Participants received oral everolimus daily for 52 weeks. Brain imaging was obtained quarterly. As primary endpoint, radiographic response (RR) was defined as ≥ 20% decrease in target VS volume. Secondary endpoints included other tumors RR, hearing outcomes, drug safety and quality of life (QOL). Results Eight participants completed the trial and four discontinued the drug early due to significant volumetric VS progression. After 52 weeks of treatment, the median annual VS growth rate decreased from 77.2% at baseline to 29.4%. There was no VS RR and 3 of 8 (37.5%) participants had stable disease. Decreased or unchanged VS volume after 3 months of treatment was predictive of stabilization at 12 months. Seven of eight participants had stable hearing during treatment except one with a decline in word recognition score. Ten of twelve participants reported only minimal changes to their QOL scores. Conclusions Volumetric imaging at 3 months can serve as an early biomarker to predict long-term sensitivity to everolimus treatment. Everolimus may represent a safe treatment option to decrease the growth of NF2-related VS in patients who have stable hearing and neurological condition. TRN: NCT01345136 (April 29, 2011).

Year:

2024

Hypothesis Transforming growth factor beta-1 (TGFβ-1) and connective tissue growth factor (CTGF) are upregulated in the implanted human cochlea. Background Cochlear implantation can lead to insertion trauma and intracochlear new tissue formation, which can detrimentally affect implant performance. TGFβ-1 and CTGF are profibrotic proteins implicated in various pathologic conditions, but little is known about their role in the cochlea. The present study aimed to characterize the expression of these proteins in the human implanted cochlea. Methods Archival human temporal bones (HTB) acquired from 12 patients with previous CI and histopathological evidence of new tissue formation as well as surgical samples of human intracochlear scar tissue surrounding the explanted CI were used in this study. Histopathologic analysis of fibrosis and osteoneogenesis was conducted using H&E. Protein expression was characterized using immunofluorescence. RNA expression from surgical specimens of fibrotic tissue surrounding the CI was quantified using qRT-PCR. Results TGFβ-1 and CTGF protein expressions were upregulated in the areas of fibrosis and osteoneogenesis surrounding the CI HTB. Similarly, surgical samples demonstrated upregulation of protein and mRNA expression of TGFβ-1 and mild upregulation of CTGF compared with control. TGFβ-1 was expressed diffusely within the fibrous capsule, whereas CTGF was expressed in the thickened portion toward the modiolus and the fibrosis-osteoneogensis junction. Conclusion To our knowledge, this is the first study to demonstrate increased expression of TGFβ-1 and CTGF in the human implanted cochlea and may provide better understanding of the mechanism behind this pathogenic process to better develop future mitigating interventions.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Phioanh Nghiemphu

Professor

University of California, Los Angeles

UNITED STATES
View details

Ivan Lopez

Adjunct Professor

David Geffen School of Medicine at UCLA

UNITED STATES
View details

Rance Fujiwara

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Jeremie Vitte

Project Scientist

University of California, Los Angeles

UNITED STATES
View details